Wild type TP53 negatively regulates the expression of the androgen receptor (AR) in prostate cancer cell lines [19] indicating that both AR and p53 regulate each other, and that intact tumor suppressor function of p53 tends to inhibit androgen signaling whereas loss of TP53 enhances AR signaling. The gene discussed is AR; the disease is prostate carcinoma.